No.142:Announcement of Cessation -Salmeterol xinafoate/ Fluticasone propionate

State Food and Drug Administration

Announcement of Administrative Protection for Pharmaceuticals



Announcement No.142 (Announcement of Cessation)


Country:                           Belgium

Applicant:                         Glaxo Wellcome Belgium S.A.

Name of the Pharmaceuticals:

        Generic Name:      Salmeterol xinafoate /Fluticasone propionate Inhaled Dry Powder

Brand Name:         Seretide Diskus

Authorization No.:        B-BE01123010

Authorization Date:      December  30, 2001


This is to announce that the administrative protection to the aforementioned pharmaceuticals granted on December  30, 2001in China has expired on June 30, 2009.



Date:   September 8, 2009.